USPTO serial 79412583
LIFEARC
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 28, 2026
- Examiner
- GEARHART, DAVID JAMES
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with LIFEARC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Britt L. Anderson
Britt L. Anderson Ashurst Perkins Coie US LLP3150 Porter Dr.Palo Alto, CA 94304United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable electronic educational and professional publications, namely, newsletters, fact sheets, and brochures about a biomedical and scientific research facility; downloadable electronic educational and professional podcasts and webcasts featuring information about biomedical and scientific research on human health and human diseases. | ACTIVE | — |
| 016 | Printed educational and professional publications, namely, printed newsletters, fact sheets, and brochures about biomedical and scientific research and information about biomedical and scientific research on human health and human diseases. | ACTIVE | — |
| 035 | Promoting research in the field of human health and human diseases through the support and coordination of research projects conducted by universities, hospitals, research foundations and businesses; business consultation services in the nature of providing assistance in the field of commercialisation of products and services by identifying routes to market for research; business assistance, management and administration services; advisory, consultancy and information services relating to all the aforesaid; compilation of scientific, medical and clinical information into computer databases; collection of business data in connection with clinical trials for business purposes. | ACTIVE | — |
| 036 | Charitable fundraising; charitable fundraising collections; organisation of collections in the nature of charitable fundraising; charitable services, namely, provision of funding for research, education, prevention and treatment of illnesses and human diseases; financial grant services, namely, providing grants for research, education, prevention, and treatment of illnesses and human diseases; provision of funding for charities in the nature of philanthropic services concerning monetary donations; charitable foundation services, namely, provision of funding for medical trials; charitable foundation services, namely, provision of funding for educational and research posts; intellectual property venture fund development and formation services for others enabling inventors of new technology to secure appropriate funding for continued technological development; technology transfer services, namely, financial asset management in the nature of managing revenue from partnered or developed intellectual property; advisory, consultancy and information services relating to all the aforesaid. | ACTIVE | — |
| 041 | Providing educational, training and mentoring services concerning the causes, prevention, detection, diagnosis, and treatment of diseases through educational conferences, seminars and written materials disseminated in connection therewith; providing educational conferences, seminars, and webinars in the field of the causes, prevention, detection, diagnosis, and treatment of diseases and dissemination of printed educational materials therewith; providing educational conferences, seminars, and webinars in the field of the causes, prevention, detection, diagnosis, and treatment of diseases and dissemination of online educational materials therewith; publishing including online publishing of journal articles, press releases, white papers and books; advisory, consultancy and information services relating to all the aforesaid. | ACTIVE | — |
| 042 | Scientific, medical and clinical research services; scientific research and scientific analysis in the field of biotechnology; scientific research and scientific analysis in the field of biochemistry; scientific research and scientific analysis in the field of biology; conducting clinical trials for others; data mining; data security consultancy services; data encryption services; database design and development; maintenance of computer software for databases; mathematical modelling services; scientific and technological services, namely, scientific research and analysis in the field of bioinformatics; drug discovery services; laboratory research in the field of medicine; computer programming and software design services; scientific research and development in the field of medical technology; research on the development and adaptation of health technology and health-related outcomes associated with implementation of health technology; clinical research services, namely, calibration, analysis and reporting of data in connection with clinical trials; conducting clinical trials for others for diagnostic tests and for pharmaceutical preparations; providing temporary use of non-downloadable web-based computer software for data integration, exchange, and analysis; providing biomedical and scientific information in the field of human health and diseases; technology transfer services, namely new product design and development services; scientific research and development services; antibody humanization services, namely antibody engineering in the nature of antibody research and development services; biopharmaceutical product development; biologic assay product development; medical research, namely, preclinical research; clinical research in the in the fields of genetic disorders, infectious diseases and rare diseases; consulting services for others in the design, planning, and implementation of project management of clinical trials; testing and inspection of pharmaceuticals in the nature of pharmacovigilance, namely, monitoring the effects of medical drugs after they have been licensed for use; advisory, consultancy and information services relating to all the aforesaid. | ACTIVE | — |
| 044 | Pharmaceutical treatment diagnostics in the nature of medical and pharmaceutical consultation; medical services; advice on medical information relating to alleviation, diagnosis, prevention and treatment of illnesses and human diseases; advisory, consultancy and information services relating to all the aforesaid. | ACTIVE | — |
| 045 | Legal services; licensing of technology, namely, patent licensing; licensing and intellectual property services in relation to technology transfer services, namely, consulting in the field of intellectual property; advisory, consultancy and information services relating to all the aforesaid. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LIFEARC
- Other trademarks owned by LIFEARC
- Other trademarks owned by LIFEARC
- Other trademarks in Class 009
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named LIFEARC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 1, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 1, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 1, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 1, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 1, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 28, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 4, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 18, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 18, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 28, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 28, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 10, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 10, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 4, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 13, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 13, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 13, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 13, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 13, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 5, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 5, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 5, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 12, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 12, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 12, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 12, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 18, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 26, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 26, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 15, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 14, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 13, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 12, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 12, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 7, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 19, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |